Categories
Procedure
Uterine Fibroid Embolization
Non-surgical treatment for uterine fibroids.
USA
Countries
Languages
- ProductsProcedure
PAE OVERVIEW
Up to 80% of women develop uterine fibroids by the time they reach age 50.3 Merit is deeply committed to uterine fibroid embolization (UFE), a non-surgical treatment option that allows a woman to keep her uterus, with the most clinically studied and proven round embolic particle and supporting tools, as well as resources for physicians and patients.
PAE PROCEDURE
WHY EMBOSPHERE® MICROSPHERES FOR UFE?
Embosphere Microspheres continue to be the embolic of choice for predictable clinical results, ease of use and long-term symptom control. Of the microspheres tested, Embosphere is the only microsphere to consistently demonstrate high infarction rates of all fibroids, which provides long-term symptom control and a significantly lower rate of reintervention.1 With Embosphere, 92.3% of patients that underwent uterine fibroid embolization (UFE) experienced complete (100%) infarction of their entire fibroid burden.2 Competing microspheres don’t compare. In addition to Embosphere, the leading spherical embolic for UFE, Merit Medical offers interventional radiologists a wide array of tools to support their UFE procedures every step of the way, whether your access is radial or femoral.
EXPLORE UFE PRODUCTS
PAE PRODUCTS
| PRODUCT | RADIAL | FEMORAL |
|
Embosphere® Procedure Pack – combines the basic products for any embolization procedure into one convenient pack. |
✔ | ✔ |
|
Rad Board Accessories – Rad Board®; Rad Rest®; Rad Trac™ |
✔ |
| PRODUCT | RADIAL | FEMORAL |
|
Merit MAK™ (Mini Access Kit) – 4 Fr or 5 Fr (will be dropped separately if not packaged with radial sheath) |
✔ | ✔ |
|
Prelude IDeal™ Hydrophilic Sheath Introducer – 11 cm; 4 Fr or 5 Fr (with or without needle access) |
✔ | |
|
PreludePRO™ Sheath Introducers – 11 cm; 4 Fr or 5 Fr |
✔ | |
|
PreludeEASE™ Hydrophilic Sheath Introducer – 11 cm; 4 Fr or 5 Fr (with or without needle access) |
✔ |
| PRODUCT | RADIAL | FEMORAL |
|
InQwire® Diagnostic Guidewires (Bentson) – 260 cm; 4 Fr or 5 Fr |
✔ | ✔ |
|
Merit Laureate® Hydrophilic Guidewires – 260 cm; 0.035”; Angled |
✔ | ✔ |
| ✔ | ✔ | |
|
Performa® Diagnostic Peripheral Catheters – Berenstein; 125 cm; 4 Fr or 5 Fr |
✔ | |
|
UAC (Uterine Artery Catheter) – 4 Fr or 5 Fr |
✔ | |
|
Performa® Angiographic Catheter – Ultimate 1, 2, 3 or 4; 110 cm or 125 cm |
✔ | |
| ✔ | ✔ | |
|
Impress® Diagnostic Peripheral Catheters – Berenstein; 4 Fr or 5 Fr |
✔ | |
|
Merit Maestro® Microcatheter – 150 cm |
✔ | ✔ |
|
SwiftNINJA® Steerable Microcatheter – 125 cm |
✔ |
| PRODUCT | RADIAL | FEMORAL |
|
Embosphere® Microspheres – 500-700 µm or 700-900 µm |
✔ | ✔ |
| ✔ | ✔ | |
| ✔ | ✔ |
| PRODUCT | RADIAL | FEMORAL |
| ✔ | ||
| ✔ | ||
| ✔ |
RESOURCES
Physician Resources
Merit offers an extensive Physician Center to support you in your UFE procedures. Downloadable resources include:
- Data & Studies
- Patient Education
- Referring Physician Materials
- Reimbursement Support
- Clinical Resources
Women’s Health Resources
Explore all the ways we’re improving the lives of women. From best-in-class technologies to data-driven resources, our Women’s Health solutions are designed to help you provide your patients with therapy options they can trust.
Ask4UFE®, is a patient education program for uterine fibroids and alternative treatment options, mainly UFE, sponsored by Merit Medical.
The program includes the patient-facing website Ask4UFE.com, social media awareness efforts and printed and digital educational tools for patients. Physicians can have access to these tools to educate their patients.
REFERENCES
- Katsumori, T, et al. CVIR 2008. Infarction of Uterine Fibroids After Embolization: Relationship Between Postprocedural Enhanced MRI Findings and Long-Term Clinical Outcomes.
- Siskin G, et al. JVIR 2008. Leiomyoma Infarction after Uterine Artery Embolization: A Prospective Randomized Study Comparing Tris-acryl Gelatin Microspheres versus Polyvinyl Alcohol Microspheres
- S. Department of Health & Human Services. (2018, Mar 16). Uterine fibroids. Retrieved from https://www.womenshealth.gov/a-z-topics/uterine-fibroids
Percentage of Patients with Complete Infarction (100%) of Entire Uterine Fibroid Tumor Burden
a) Siskin, G. P., Beck, A., Schuster, M., et al. (2008). Leiomyoma infarction after uterine artery embolization: A prospective randomized study comparing tris-acryl gelatin microspheres versus polyvinyl alcohol microspheres. J Vasc Interv Radiol, Jan;19(1):58-65.
b) Smeets, A. J., Nijenhuis, R. J., van Rooij, W. J., et al. (2010). Embolization of uterine leiomyomas with polyzene F-coated hydrogel microspheres: Initial experience. J Vasc Interv Radiol, Dec;21(12):1830-1834.
c) Chrisman, H. B., Dhand, S., Rajeswaran, S., et al. (2010). Prospective evaluation of the embolic agent Bead Block in the treatment of uterine leiomyomas with uterine artery embolization: A phase II study. J Vasc Interv Radiol, Apr;21(4):484-489.
d) Searched pubmed.gov and Google Scholar for the following keywords and combinations: “uterine artery embolization”, “UFE”, “HydroPearl”, “GelBead”, “OptiSphere”, “uterine artery embolization”, “UAE”, “leiomyomas”, “uterine fibroid infarction”, “UFE”.